Medical Treatments in China
World-class healthcare at a fraction of Western prices. Browse 509 treatments and compare costs for international patients.
42 treatments in Immune & Blood
Bone Marrow Transplant
骨髓移植
Bone marrow transplantation (hematopoietic stem cell transplant) in China is performed at nationally designated transplant centers with extensive experience in both autologous and allogeneic transplants. Chinese hematologists have pioneered haploidentical (half-matched) transplant techniques that have achieved internationally recognized outcomes. China's large donor registry and advanced HLA typing capabilities facilitate donor matching for international patients.
Kidney Transplant
肾移植手术
Kidney transplantation in China is performed at nationally designated transplant centers with stringent oversight. China has reformed its organ donation system with a voluntary citizen-based organ donation program (CDCD) and computerized organ allocation system (COTRS). Leading transplant centers achieve graft survival rates comparable to international standards. For international patients with a living donor (family member), the process can be coordinated with pre-transplant evaluation and post-transplant management.
Liver Transplant
肝移植
China performs the second-most liver transplants globally with a transparent allocation system through COTRS (China Organ Transplant Response System). Leading centers include Tianjin First Central Hospital, Zhejiang University First Affiliated Hospital, and Zhongshan Hospital in Shanghai, each performing hundreds of transplants annually. Patients benefit from shorter waitlist times than many Western countries and 80-85% cost savings versus US transplant programs.
Heart Transplant
心脏移植
Orthotopic heart transplantation for end-stage heart failure at China's premier cardiac transplant centers including Fuwai Hospital, Union Hospital Wuhan, and Anzhen Hospital, which collectively perform over 700 heart transplants annually. China's cardiac transplant programs have achieved 1-year survival rates exceeding 90% and 5-year survival above 80%, with comprehensive pre-transplant evaluation, surgical expertise, and post-transplant immunosuppression management.
Cornea Transplant Program
角膜移植项目
Advanced corneal transplantation including penetrating keratoplasty (PKP), Descemet's membrane endothelial keratoplasty (DMEK), and deep anterior lamellar keratoplasty (DALK) for keratoconus, corneal dystrophies, and scarring. China's leading eye hospitals perform over 5,000 corneal transplants annually, with growing expertise in partial-thickness (lamellar) techniques that offer faster recovery and lower rejection rates.
Stem Cell Transplant for Leukemia
白血病干细胞移植
Allogeneic hematopoietic stem cell transplantation (HSCT) for acute and chronic leukemias using matched related, unrelated, or haploidentical donors. China's HSCT centers, particularly Peking University People's Hospital under the Beijing Protocol, have pioneered haploidentical transplantation techniques that achieve outcomes comparable to matched unrelated donor transplants, dramatically expanding the donor pool and reducing wait times for patients without a matched sibling.
Aplastic Anemia Treatment
再生障碍性贫血治疗
Comprehensive aplastic anemia management including immunosuppressive therapy (ATG + cyclosporine + eltrombopag), supportive care, and allogeneic stem cell transplantation for severe cases. China's hematology centers have extensive experience treating aplastic anemia with both IST and transplant approaches, with particular expertise in haploidentical HSCT for patients lacking matched donors, offering cure rates of 80-90% in young patients.
Thalassemia Treatment
地中海贫血治疗
Comprehensive thalassemia management including optimized transfusion therapy, iron chelation, and curative allogeneic hematopoietic stem cell transplantation. Southern China (Guangxi, Guangdong, Hainan) has the highest thalassemia prevalence globally, resulting in world-leading clinical expertise and transplant volumes. Gene therapy clinical trials using CRISPR-based approaches are also underway at select centers, offering potential future cures without donor dependency.
Pancreas Transplant
胰腺移植
Pancreas transplantation for Type 1 diabetes, performed as simultaneous pancreas-kidney (SPK), pancreas after kidney (PAK), or pancreas transplant alone (PTA) at China's specialized transplant centers. The procedure offers insulin independence and normalization of glycemic control, preventing progression of diabetic complications. China's growing pancreas transplant programs achieve graft survival rates comparable to international registries at substantially reduced costs.
Rheumatoid Arthritis Treatment
类风湿关节炎治疗
Comprehensive rheumatoid arthritis treatment combining DMARDs, biologics, and traditional Chinese medicine approaches. China's top rheumatology centers offer advanced biologic therapies including TNF inhibitors and IL-6 blockers at significantly lower costs. Integrated TCM therapies such as acupuncture and herbal medicine provide additional symptom relief and immune modulation.
Lupus (SLE) Treatment
系统性红斑狼疮治疗
Multidisciplinary systemic lupus erythematosus management utilizing immunosuppressants, biologics, and organ-specific interventions. China has extensive clinical experience treating lupus given its higher prevalence in Asian populations. Leading centers like Peking Union Medical College Hospital offer cutting-edge treatments including belimumab and novel targeted therapies.
Ankylosing Spondylitis Treatment
强直性脊柱炎治疗
Targeted treatment for ankylosing spondylitis using TNF inhibitors, IL-17 blockers, and structured rehabilitation programs. Chinese rheumatology centers provide comprehensive spinal care combining advanced biologics with physical therapy and TCM modalities. Early intervention protocols help prevent spinal fusion and maintain mobility.
Not sure which treatment is right for you?
Our AI assistant can help you explore options and answer your questions.